Geneoscopy, Inc. raised $105 million in a Series C funding round led by Bio-Rad Laboratories to advance their at-home colorectal cancer screening test, ColoSense.
Amount Raised
$105 Million
Round Type
Series C
St. LouisBiotechnologyHealthcareHealth CareTherapeuticsHealth DiagnosticsInvestors
Description
Geneoscopy, Inc. has successfully closed a Series C funding round, raising $105 million to further the development of its gastrointestinal diagnostic tests. The funding will facilitate the launch of the ColoSense test and ongoing investment in innovative diagnostic solutions for inflammatory bowel disease.
Quick answer
Geneoscopy raised $105 Million in a Series C round, dated January 8, 2025. Investors: Bio-Rad Laboratories, Nt Investments, Lightchain Capital, Mercy Health, Granger Management, Petrichor, Labcorp and Morningside Ventures. Geneoscopy is based in St. Louis, Missouri, United States.
- How much did Geneoscopy raise?
- Geneoscopy raised $105 Million in a Series C round on January 8, 2025.
- Who invested in Geneoscopy?
- Bio-Rad Laboratories, Nt Investments, Lightchain Capital, Mercy Health, Granger Management, Petrichor, Labcorp and Morningside Ventures are named as investors in this round.
- What does Geneoscopy do?
- Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics.
- Where is Geneoscopy based and how big is it?
- Geneoscopy is based in St. Louis, Missouri, United States. Fundz records about 63 employees.
- Who are the decision-makers at Geneoscopy?
- Fundz holds 1 contact at Geneoscopy. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Geneoscopy that raised within 45 days of this round, from Fundz verified event records.
- Diag-Nose.io raised $2M (Seed) on January 30, 2025.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
- Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
- Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
- NewcelX raised $500K (Seed) on January 7, 2025.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
Who to call at Geneoscopy, and when
A new round usually means Geneoscopy is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneoscopy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneoscopy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneoscopy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneoscopy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Geneoscopy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.